ADVFN - Advanced Financial Network.
HOME» NYSE » D » DVA Stock Price » DVA Stock News

Davita Share News

 Davita Inc. Stock Price
DVA Stock Price
 Davita Inc. Stock Chart
DVA Stock Chart
 Davita Inc. Stock News
DVA Stock News
 Davita Inc. Company Information
DVA Company Information
 Davita Inc. Stock Trades
DVA Stock Trades

DaVita Agrees to $55 Million Settlement

DaVita Inc. (DVA) agreed to pay roughly $55 million in a settlement of a lawsuit filed by an individual in 2002 related to the anemia drug Epogen. The dialysis-service provider said the agreement, which also includes the payment of attorneys fees, contains no findings of wrongdoing or admission of liability by the company. "DaVita and its affiliated physicians did nothing wrong and stand by their anemia management practices," the company said. In a previous SEC filing, the company identified the individual as Ivey Woodard and said it was served with a complaint under the qui tam provisions of the federal False Claims Act. DaVita also said the government investigated allegations raised by the individual; however, it chose not to file claims against DaVita. DaVita's shares closed at $97.62 on Monday and were inactive premarket. The stock is up 29% year-to-date. Write to Saabira Chaudhuri at [email protected]

Stock News for Davita (DVA)
DateTimeHeadline
01/12/201722:32:00Judge Blocks Rule That Could Limit Premium Assistance for Dialysis...
01/11/201713:17:08Statement of Changes in Beneficial Ownership (4)
01/11/201713:16:40Initial Statement of Beneficial Ownership (3)
01/10/201717:06:00SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On...
01/10/201710:34:00SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation...
01/10/201710:10:00SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces...
01/09/201717:02:00DAVITA NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors...
01/09/201715:51:00EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities...
01/09/201706:50:00DaVita Inc. to Present at the 35th Annual J.P. Morgan Healthcare...
01/09/201706:06:48Current Report Filing (8-k)
01/09/201706:00:00DaVita Enters Into New Sourcing and Supply Agreement with Amgen...
01/06/201717:15:00Dialysis Community Seeks Emergency Relief to Block CMS' Unlawful...
01/05/201717:37:00DaVita Appoints Pascal Desroches to Board of Directors
01/05/201717:37:00DaVita Announces Joel Ackerman to be CFO
01/05/201717:20:06Current Report Filing (8-k)
01/05/201717:19:14Current Report Filing (8-k)
01/04/201706:13:00Military-Friendly Employer for 8th Consecutive Year
12/29/201616:46:00DaVita Celebrates 2016 Achievements
12/29/201613:51:00DaVita Celebrates 2016 Achievements
12/22/201610:17:00HealthCare Partners Nevada to Acquire WellHealth Quality Care

Davita and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US